迈得医疗工业设备股份有限公司 关于公司 2025 年度提质增效重回报专项行动方案的半 年度评估报告 迈得医疗工业设备股份有限公司（以下简称"公司"）为践行"以投资者为本"的上 市公司发展理念，推动公司持续优化经营、规范治理和积极回报投资者，大力提高 公司质量，助力信心提振、资本市场稳定和经济高质量发展，公司董事会审议通过 了《2025 年度"提质增效重回报"行动方案》。2025 年上半年，该行动方案执行情况 如下： 一. 聚焦经营主业 作为医用耗材智能装备的领先企业，公司具备智能装备与医疗器械产业的双重特 征，主要从事医用耗材智能装备的研发、生产、销售和服务，有效整合医疗器械产 品工艺、自动化、软件等方面的技术，形成独特的产品与服务优势，为医用耗材生 产企业提供自动化成套设备和软件服务整体式解决方案。公司始终坚持以"顾问式营 销、定向式研发、精细化生产、终身式服务"为经营方针，以"用心创造、推动医疗 器械产业升级"为使命，以"成为全球医用耗材自动化领先者"为愿景，围绕核心业务 积极寻求稳步扩张。 公司现已拥有成熟的、国内领先的安全输注类与血液净化类智能装备技术与优质 产品线，是国际上领先的透析器耗材设备供应商 ...

迈得医疗公告，2025年上半年营业收入1.41亿元，同比下降14.75%。净利润604.51万元，同比下降 38.81%。 ...

Market Overview - On August 27, the automation equipment sector declined by 1.04%, with MaiDe Medical leading the losses [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable gainers in the automation equipment sector included: - MaiHe Co., Ltd. (301199) with a closing price of 30.73, up 4.59% [1] - Lianying Laser (688518) at 23.63, up 3.41% [1] - Bozhong Precision (688097) at 35.70, up 3.03% [1] - Conversely, significant decliners included: - MaiDe Medical (688310) at 19.23, down 6.24% [2] - Zhilifang (301312) at 52.80, down 5.78% [2] - Sitai Ke (301568) at 50.22, down 5.69% [2] Capital Flow - The automation equipment sector experienced a net outflow of 9.71 billion yuan from institutional investors, while retail investors saw a net inflow of 11.88 billion yuan [2][3] - Key stocks with notable capital flows included: - Huagong Technology (000988) with a net inflow of 76.58 million yuan from institutional investors [3] - Jintuo Co., Ltd. (300400) with a net inflow of 65.24 million yuan from institutional investors [3] - Zhilifang (301312) with a net outflow of 64.5 million yuan from institutional investors [3]

Group 1 - The core viewpoint of the news is that Maide Medical's stock has experienced a decline of 5.07%, with a current price of 19.47 CNY per share and a total market capitalization of 3.236 billion CNY [1] - Maide Medical, established on March 10, 2003, and listed on December 3, 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1] - The main revenue composition of Maide Medical includes: 42.18% from safety infusion line machines, 37.90% from blood purification line machines, 14.04% from safety infusion single machines, and 5.87% from other categories [1] Group 2 - Among the top ten circulating shareholders of Maide Medical, a fund under Rongtong Fund holds a position, having reduced its holdings by 156 shares in the first quarter, now owning 2.5998 million shares, which is 1.56% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund (000727) has a current scale of 2.074 billion CNY and has achieved a return of 23.63% this year, ranking 3072 out of 8194 in its category [2] - The fund has a one-year return of 47%, ranking 2642 out of 7963, and a cumulative return since inception of 198.7% [2]

证券时报·数据宝统计，截至今日下午13:59，上证综指3884.87点，收于五日均线之上，涨跌幅0.03%， A股总成交额为21403.55亿元。到目前为止，今日有832只A股价格突破了五日均线，其中乖离率较大的 个股有嘉亨家化、久祺股份、迈得医疗等，乖离率分别为14.97%、14.66%、12.65%；博盈特焊、一彬 科技、永安行等个股乖离率较小，刚刚站上五日均线。 8月26日突破五日均线个股乖离率排名 | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 五日均线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 300955 | 嘉亨家 化 | 20.02 | 22.59 | 21.33 | 24.52 | 14.97 | | 300994 | 久祺股 份 | 19.99 | 13.72 | 18.95 | 21.73 | 14.66 | | 688310 | 迈得医 疗 | 18.99 | 12.32 | 18.75 | 21.12 | 12.65 ...

Group 1 - The core point of the news is that MaiDe Medical's stock experienced a significant increase, reaching a limit up of 20.00% during trading on August 26, with a price of 21.30 yuan and a trading volume of 2.05 billion yuan [2] - Among the stocks listed on the Sci-Tech Innovation Board, a total of 262 stocks were reported to be rising, with 10 stocks showing an increase of over 10%, including MaiDe Medical, KaiPu Cloud, and Electric Wind Power [2] - Conversely, 315 stocks were reported to be declining, with notable decreases in stocks such as JingSong Intelligent, ShengKe Communication-U, and Chip Origin, which fell by 9.41%, 9.20%, and 9.02% respectively [2] Group 2 - In terms of capital flow, MaiDe Medical saw a net outflow of 27.82 million yuan in the previous trading day, with a total net outflow of 40.42 million yuan over the past five days [3] - The latest margin trading data as of August 25 indicates that the margin balance for MaiDe Medical is 73.09 million yuan, which represents a decrease of 0.37% from the previous trading day [3] - Over the past ten days, the total margin balance has increased by 10.06 million yuan, reflecting a growth rate of 15.97%, with the financing balance also growing by the same percentage [3]

融券方面，当日融券卖出0.00万股，净卖出0.00万股。 来源：金融界 最近三个交易日，20日-22日，迈得医疗分别获融资买入0.03亿元、0.08亿元、0.16亿元。 8月22日，沪深两融数据显示，迈得医疗获融资买入额0.16亿元，居两市第1250位，当日融资偿还额0.11 亿元，净买入438.98万元。 ...

Core Viewpoint - The stock of Maide Medical (688310) has shown a significant increase of 4.67% on August 21, 2025, closing at 18.59 yuan, despite a net outflow of major funds [1][2]. Financial Performance - Maide Medical reported a main revenue of 40.18 million yuan for Q1 2025, a year-on-year decline of 45.87% [4]. - The net profit attributable to shareholders was -10.80 million yuan, representing a year-on-year decrease of 202.7% [4]. - The company’s gross profit margin stands at 32.89%, which is higher than the industry average of 27.3% [4]. Market Position - The total market capitalization of Maide Medical is 3.09 billion yuan, significantly lower than the industry average of 7.58 billion yuan [4]. - The company ranks 202nd out of 265 in terms of total market value within the specialized equipment industry [4]. - The price-to-earnings ratio (P/E) is -71.55, indicating negative earnings, while the industry average is 81.71 [4]. Fund Flow Analysis - On August 21, 2025, the net outflow of major funds was 2.41 million yuan, accounting for 1.89% of the total transaction amount [1]. - Retail investors showed a net inflow of 2.95 million yuan, representing 2.30% of the total transaction amount on the same day [1]. - Over the past five days, the trend indicates a consistent net outflow from major funds, with a total net outflow of 4.43 million yuan on August 20, 2025 [1][2]. Financing and Margin Trading - As of August 21, 2025, the financing balance is 68.97 million yuan, with a net repayment of 10.46 million yuan on that day [2]. - There were no shares sold or repaid in the margin trading segment, indicating no activity in this area [2].

Group 1 - The latest stock price of Maide Medical is 18.59 yuan, an increase of 0.83 yuan, representing a rise of 4.67% compared to the previous trading day [1] - The trading volume for the day was 68,290 hands, with a transaction amount reaching 128 million yuan [1] - Maide Medical operates in the medical device industry, focusing on the research, production, and sales of intelligent equipment for medical consumables [1] Group 2 - The company's products are primarily used in the production of medical consumables, including automated production equipment for infusion sets and syringes [1] - Recently, the company has made progress in expanding its overseas market, with foreign orders exceeding 60 million yuan by the end of 2024 [1] - The company is enhancing its international visibility through exhibitions and client visits, resulting in a noticeable increase in the frequency of visits from overseas clients [1] Group 3 - In terms of capital flow, Maide Medical experienced a net outflow of 2.41 million yuan in main funds on that day, with a cumulative net outflow of 28.15 million yuan over the past five days [1]

Core Viewpoint - The stock of Maide Medical (688310) has shown a decline in price and significant net outflow of main funds, indicating potential challenges in investor sentiment and financial performance [1][2]. Financial Performance - As of August 20, 2025, Maide Medical's stock closed at 17.76 yuan, down 0.67% with a trading volume of 28,300 lots and a transaction amount of 50.54 million yuan [1]. - The company's Q1 2025 report revealed a main revenue of 40.18 million yuan, a year-on-year decrease of 45.87%, and a net profit attributable to shareholders of -10.80 million yuan, a decline of 202.7% [3]. - The company's gross profit margin stands at 32.89%, which is higher than the industry average of 27.19% [3]. Fund Flow Analysis - On August 20, 2025, the main funds experienced a net outflow of 4.43 million yuan, accounting for 8.77% of the total transaction amount, while retail funds saw a net outflow of 0.50 million yuan [1][2]. - Over the past five days, the main funds have consistently shown net outflows, with the largest outflow recorded on August 18, 2025, at 11.64 million yuan [2]. Industry Comparison - Maide Medical's total market capitalization is 2.95 billion yuan, significantly lower than the industry average of 7.68 billion yuan, ranking 212 out of 265 in the specialized equipment industry [3]. - The company's net asset value is 817 million yuan, also below the industry average of 2.27 billion yuan, ranking 200 out of 265 [3]. - The price-to-earnings ratio (P/E) is -68.35, indicating negative earnings, while the industry average P/E is 94.78 [3].